Table 2.
Group | Mother's HBI status (total no.) | No. (%) of teenagers with indicated HBI status |
No. (%) of anti-HBc+ teenagers | ||
---|---|---|---|---|---|
HBIb | Non-HBI |
||||
Anti-HBs+ | Anti-HBs− | ||||
① | HBI (40) | 2 (5.0) | 26 (65.0) | 12 (30.0) | 4 (10.0) |
② | hnHBI, HBV DNA+ (6) | 1* (16.7) | 2 (33.3) | 3 (50.0) | 0 (0.00) |
③ | hpHBI, HBV DNA+ (25) | 1# (4.0) | 18 (72.0) | 6 (24.0) | 4 (16.0) |
④ | hpHBI, HBV DNA− (9) | 0 (0.0) | 6 (66.7) | 3 (33.3) | 0 (0.00) |
⑤ | Non-HBI (53) | 1* (1.9) | 30 (56.6) | 22 (41.5) | 0 (0.00) |
Total | 3 (3.2) | 56 (60.2) | 34 (36.6) | 4 (4.3) |
HBI, hepatitis B virus infection; HBV, hepatitis B virus; anti-HBs, antibody to hepatitis B virus surface antigen; anti-HBc, antibody to hepatitis B virus core antigen. Statistical significance was determined by Fisher's exact test. For teenagers' HBI statuses, overall P = 0.46 for ① and ⑤, P = 0.14 for ②, ③ plus ④, and ⑤, P = 0.28 for ②, ③, ④, and ⑤, P = 0.63 for ② plus ③, ④, and ⑤, and P = 1.00 for ② plus ⑤ and ③ plus ④. For teenagers' anti-HBc statuses, overall P = 0.04 for ① and ⑤, P = 0.05 for ②, ③ plus ④, and ⑤, P = 0.02 for ②, ③, ④, and ⑤, P = 0.02 for ② plus ③, ④, and ⑤, and P = 0.02 for ② plus ⑤ and ③ plus ④.
*, hnHBI; #, hpHBI.